Rhenman & Partners Asset Management Ab Nevro Corp Transaction History

Rhenman & Partners Asset Management Ab

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 Apr 11, 2018	SELL	$69.46 - $88.57 $1.05 Million - $1.34 Million	-15,145 Closed	0 $0
Q4 2017 Jan 19, 2018	SELL	$65.94 - $93.31 $7.57 Million - $10.7 Million	-114,855 Reduced 88.35%	15,145 $1.05 Million
Q3 2017 Oct 13, 2017	BUY	$80.87 - $91.08 $10.5 Million - $11.8 Million	130,000	130,000 $11.8 Million

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $140M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.